Scotts Miracle-Gro (SMG) Tops Q4 EPS by 2c, Offers FY22 Guidance

Scotts Miracle-Gro (NYSE: SMG) reported Q4 EPS of ($0.82), $0.02 better than the analyst estimate of ($0.84). Revenue for the quarter came in at $797.8 million versus the consensus estimate of $689.22 million.

GUIDANCE:

Scotts Miracle-Gro sees FY2022 EPS of $8.50-$8.90, versus the consensus of $8.52.

• The Company established guidance for fiscal 2022 based on expected company-wide sales growth of 0 to 3 percent. It expects U.S. Consumer segment sales to be 0 to minus 4 percent.

For earnings history and earnings-related data on Scotts Miracle-Gro (SMG) click here.

You May Also Be Interested In

• Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
• Mizuho Resumes Spire (SR) at Outperform
• AbbVie updates 2026 EPS guidance after $291M IPR&D charge